Senior Vice President / Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center, Vaccines & Infectious Disease 1100 Eastlake Ave E, E5-110 Seattle, WA 98109
Dr. McElrath is a key scientific leader in the development of a clinically effective HIV vaccine. She has mentored numerous junior PhD and MD faculty, young investigators and graduate students in their career paths.
Julie McElrath established a global laboratory platform to elucidate immunity and protective correlates of an effective HIV vaccine, serving as a framework for pathogen vaccines of public health importance.
Related to this effort, she is the Principal Investigator of the HIV Vaccine Trials Network Laboratory Center & the Seattle Vaccine Unit funded by the National Institutes of Health and the Bill and Melinda Gates Foundation Adjuvant CAVD.
Her translational research pursues both a vaccine that will protect against HIV infection and a deeper understanding of the components of immunity that contribute to control of HIV disease.